Creating the Future of Cancer Treatment
For more than 24 years, King's Daughters Medical Center has worked with some of the top names in the field of cancer research to advance knowledge and treatment for all patients here in the Tri-State and throughout the world.
King's Daughters Oncology Research Department enrolled its first patient in a cancer research trial in June 1988. That research was designed to assess the effectiveness of a certain medication in the treatment of breast cancer, part of the National Surgical Adjuvant Breast and Bowel Project in partnership with the Markey Cancer Center at the University of Kentucky.
Since that time, KDMC has enrolled nearly 500 cancer patients in 85 research studies investigating the effectiveness of new medications, medication combinations, prevention strategies and early detection efforts.
Research protocols are offered through the Kentucky Clinical Trials Network, Southwest Oncology Group, the National Surgical Adjuvant Breast and Bowel Project and the National Cancer Institute's Clinical Trials Support Unit.
Providing access to clinical trials in Ashland means that patients who could benefit from cutting-edge research can receive it without the long drive or hassle of going to a large urban center.
Over the years, patients at KDMC have helped researchers fine-tune and develop new approaches for the treatment of many kinds of cancer.
Our Cancer Committee is dedicated to teaching prevention and healthy lifestyle choices; offering screening and early detection programs; and delivering world-class care throughout the region.